Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -28.50%138.86M | 34.95%476.2M | -28.70%90.72M | -22.75%49.36M | 7.76%146.99M | 554.79%194.22M | 13.01%352.88M | -3.54%127.24M | 71.39%63.89M | 161.97%136.41M |
| Cost of revenue | -31.85%97.19M | 7.28%346.94M | -45.66%61.41M | -44.32%33.03M | -9.34%115.17M | 464.47%142.62M | 7.02%323.39M | -15.31%113M | 59.58%59.31M | 192.91%127.03M |
| Gross profit | -19.24%41.67M | 338.36%129.26M | 105.86%29.31M | 256.84%16.33M | 239.40%31.82M | 1,073.89%51.6M | 192.80%29.49M | 1,030.31%14.24M | 4,098.17%4.58M | 7.75%9.38M |
| Operating expense | -10.85%32.64M | 412.54%77.2M | 64.71%16.54M | 394.79%11.22M | 258.26%26.02M | 744.66%36.62M | 12.65%15.06M | 185.95%10.04M | -78.63%2.27M | 95.53%7.26M |
| Staff costs | -8.00%30.88M | 412.54%77.2M | 98.46%17.61M | 236.99%8.57M | 716.51%19.54M | 1,161.10%33.56M | 12.65%15.06M | 187.44%8.87M | -21.43%2.54M | -24.77%2.39M |
| Other operating expenses | -42.18%1.77M | -13.85%11.11M | -191.86%-1.07M | --2.64M | 33.05%6.48M | 82.68%3.06M | --12.89M | --1.17M | ---- | 813.51%4.87M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --277K | ---- |
| Operating profit | -39.75%9.03M | 260.91%52.06M | 204.26%12.77M | 121.39%5.11M | 174.59%5.8M | 24,470.49%14.99M | 537.16%14.43M | -58.64%4.2M | 121.99%2.31M | -57.63%2.11M |
| Net non-operating interest income (expenses) | 52.73%-571K | 15.06%-3.41M | -14.59%-1.23M | -29.13%-789K | 34.80%-1.05M | 24.78%-1.21M | 17.59%-4.01M | -397.25%-1.07M | 79.70%-611K | -69.11%-1.62M |
| Non-operating interest income | ---- | 59.65%901.47K | ---- | ---- | ---- | ---- | 14.28%564.67K | ---- | ---- | ---- |
| Non-operating interest expense | -52.73%571K | -5.84%4.31M | 14.59%1.23M | 29.13%789K | -34.80%1.05M | -24.78%1.21M | -14.65%4.58M | 694.97%1.07M | -79.70%611K | 69.11%1.62M |
| Net investment income | 2,297.30%1.3M | -94.44%54.24K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | -150.97%-1.28M | 0 | 0 | 0 | 183.10%10.11M | 1,409.30%2.51M | 35.95%2.55M | 153.83%1.19M | |
| Special income (charges) | 75.85M | -23.52%14.9M | -100.34%-5K | 0 | 0 | 253.52%19.49M | 1.45M | 15.08M | ||
| Less:Other special charges | ---75.92M | 95.45%-914.5K | ---- | ---- | ---- | ---- | -629.40%-20.08M | ---4.8M | ---15.08M | ---- |
| Less:Write off | --68K | -2,459.52%-13.99M | 100.34%5K | ---- | ---- | --0 | -96.16%592.88K | ---1.45M | ---- | ---- |
| Other non-operating income (expenses) | 186.96%3.17M | -33.95%-20.02M | -765.79%-8.88M | 184.93%11.65M | 1,266.69%16.95M | 188.25%1.1M | -142.19%-14.94M | -94.31%1.33M | 2,158.56%4.09M | -87.40%1.24M |
| Income before tax | 487.73%87.48M | 78.49%44.84M | -83.54%1.39M | -31.78%15.97M | 641.24%21.7M | 450.65%14.88M | 31.47%25.12M | -61.76%8.43M | 304.35%23.41M | -74.90%2.93M |
| Income tax | 89.38%7.85M | 217.18%8M | 39.81%8.44M | -248.85%-7.29M | 1,091.41%3.05M | 4.14M | 280.29%2.52M | 285.83%6.04M | 37,784.62%4.9M | 1,166.67%256K |
| Net income | 641.43%79.63M | -20.09%43.39M | -394.82%-7.05M | 25.66%23.26M | 598.09%18.65M | 297.34%10.74M | 194.38%54.3M | -88.32%2.39M | 261.77%18.51M | -77.14%2.67M |
| Net income continuous operations | 641.43%79.63M | 63.01%36.84M | -394.82%-7.05M | 25.66%23.26M | 598.09%18.65M | 297.34%10.74M | 22.52%22.6M | -88.32%2.39M | 261.77%18.51M | -77.14%2.67M |
| Net income discontinuous operations | ---- | -79.33%6.55M | ---- | ---- | ---- | ---- | --31.7M | ---- | ---- | ---- |
| Noncontrolling interests | -0.29%3.06M | 37,157.19%11.65M | 9,612.90%2.95M | 2.52M | 3.12M | 3.07M | 96.80%-31.43K | 99.08%-31K | 0 | 0 |
| Net income attributable to the company | 897.71%76.57M | -41.57%31.75M | -512.75%-10M | 12.03%20.74M | 481.28%15.53M | 183.94%7.68M | 179.67%54.34M | -89.83%2.42M | 260.95%18.51M | -69.38%2.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 897.71%76.57M | -41.57%31.75M | -512.75%-10M | 12.03%20.74M | 481.28%15.53M | 183.94%7.68M | 179.67%54.34M | -89.83%2.42M | 260.95%18.51M | -69.38%2.67M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 591.33%0.2659 | -41.69%0.1592 | -506.24%-0.05 | 11.57%0.1038 | 494.11%0.0777 | 150.00%0.0385 | 179.53%0.2731 | -89.73%0.0123 | 251.25%0.0931 | -71.67%0.0131 |
| Diluted earnings per share | 591.33%0.2659 | -41.69%0.1592 | -506.24%-0.05 | 11.57%0.1038 | 494.11%0.0777 | 150.00%0.0385 | 179.53%0.2731 | -89.73%0.0123 | 251.25%0.0931 | -71.67%0.0131 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.